Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hans Rudolph is a private U.S. respiratory medical device company that designs and manufactures valves, masks, pneumotachometers, calibration syringes, lung simulators, connectors, and related instrumentation for respiratory care, pulmonary function testing, sleep medicine, research, and OEM customers. The company traces its roots to the 1930s and was incorporated in 1960, with the business still operating as an active family-run manufacturer in Kansas. Its product portfolio includes CPAP/BiLevel/NIV oro-nasal masks, breathing valves, flow measurement systems, data acquisition systems such as SmartLab, and accessories used in hospitals, clinics, laboratories, and home-care settings. Hans Rudolph appears to be a niche commercial-stage healthcare manufacturer rather than a drug-development biotech company, with revenues generated from marketed respiratory products sold directly and through distributors worldwide.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hans Rudolph.